Westminster Irbesartan recalls
The FDA has published 3 recalls involving Westminster Irbesartan since 2018. The latest was reported on 19 Dec 2018. Most were for nitrosamine impurity. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 19 Dec 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why westminster irbesartan is recalled
Companies
By year
All westminster irbesartan recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Westminster Irbesartan Tablets, USP 150 mg recalled | Westminster Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Westminster Irbesartan Tablets, USP 300 mg recalled | Westminster Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Westminster Irbesartan Tablets, USP 75 mg recalled | Westminster Pharmaceuticals | Nitrosamine Impurity | Nationwide |
Should you stop taking Westminster Irbesartan?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.